{"id":"W2577857478","doi":"10.1182/blood.v118.21.5170.5170","title":"A Ruxolitinib Individual Supply Program for Patients with Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Discontinuation; International Prognostic Scoring System; Internal medicine; Anemia; Adverse effect; Clinical endpoint; Placebo; Polycythemia vera; Essential thrombocythemia; Clinical trial; Gastroenterology; Surgery; Myelodysplastic syndromes; Bone marrow; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002164922,0.0001447954,0.0001624192,0.0002084108,0.0003595995,0.0001841148,0.0001506967,0.0002575539,0.009671431],"category_scores_gemma":[0.0005828144,0.00008207485,0.0001885449,0.0003138411,0.00009895465,0.0002091338,0.0003233406,0.0003178707,0.0008597387],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002250693,"about_ca_system_score_gemma":0.0004465524,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004789652,"about_ca_topic_score_gemma":0.001130984,"domain_scores_codex":[0.9999075,0.00003101047,0.00000826839,0.00001983605,0.00001154638,0.00002184326],"domain_scores_gemma":[0.9995694,0.00006724788,0.0001476691,0.00001869332,0.00002187802,0.0001751503],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02484978,0.009298168,0.2511563,0.0006156962,0.0002244838,0.001607845,0.0003892891,0.0011116,0.007093872,0.0005037796,0.03730311,0.6658462],"study_design_scores_gemma":[0.02016511,0.08384456,0.7885394,0.0004475532,0.0007996597,0.007291057,0.0005785078,0.007191638,0.006232207,0.0007866573,0.08407276,0.00005087454],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9792626,0.001245832,0.001057461,0.0007074492,0.00004805867,0.0006582779,0.0006712853,0.0001947063,0.01615437],"genre_scores_gemma":[0.9939269,0.0005748494,0.001056283,0.0004941212,0.0001275957,0.0004702131,0.0008315676,0.000008360779,0.002510087],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009671431,"threshold_uncertainty_score":0.03235412,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01629583205061588,"score_gpt":0.2501240779281107,"score_spread":0.2338282458774948,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}